BioCentury
ARTICLE | Company News

Teva sales and marketing update

December 22, 2014 8:00 AM UTC

Teva launched a generic version of amlodipine/valsartan/hydrochlorothiazide in the U.S. to treat hypertension. Novartis AG (NYSE:NVS; SIX:NOVN, Basel, Switzerland) markets the combination of the cal...